The “High Sensitivity Molecular Imaging (IMAS)” project is an initiative led by the Department of Universal Health and Public Health of the Generalitat Valenciana, with a budget of 7,500,000 euros, 50% financed by the European Regional Development Fund (ERDF), through a grant of 3,750,000 euros from the Ministry of Science and Innovation.
This project is part of the Healthcare actions to promote Public Procurement of Innovation (PPI) and represents an important step forward in the improvement of public health services and the support of innovative companies.
IMAS aims to develop a new positron emission tomography (PET) device that exceeds the capabilities of current equipment, improving its sensitivity and spatial resolution. PET devices are essential for obtaining molecular images, using specific radiopharmaceuticals to generate functional images of organs or metabolic processes. This technology is crucial in areas such as oncology and neurology, both for initial diagnosis and for evaluating the response to treatment and the evolution of patients. In addition, its application extends to areas such as psychiatry, cardiology and radiotherapy planning.
Project objectives:
- To develop highly sensitive molecular imaging equipment, both instrumentally and in data processing.
- To improve diagnostic accuracy and the evaluation of response to treatments in various pathologies, with special relevance in pediatric patients.
- Expand the use of full-body PET in hospitals, investigating new technologies to create a technically and economically viable solution.
- Promote innovation in technology companies, facilitating the implementation of demonstration projects through Public Procurement of Innovation.
Expected achievements with this new equipment: The new equipment will allow significant advances in the diagnosis and treatment of various diseases, improving the accuracy of the images and monitoring the evolution of patients.
